Published: Nov 26, 2020, 21:05 IST | Updated: Nov 26, 2020, 21:05 IST
Pascal Soriot, CEO of AstraZeneca said that the British-Swedish pharma company is likely to conduct an additional global trials to further assess the efficacy of its COVID-19 vaccine.